Skip to main content

Aspen Group, Inc. Amends and Extends Debt Agreement

Maturity Date Extended by One Year to May 2027Quarterly Principal Amortization Payment Reduced PHOENIX, May 11, 2026 (GLOBE NEWSWIRE) — Aspen Group, Inc. (“AGI” or the “Company”) (OTCQB: ASPU), an education technology holding company and the parent company of Aspen University, Inc. (“AU”) and United States University, Inc. (“USU”), announced today it entered into a Seventh Amendment to its 15% Senior Secured Debentures with JGB Management Inc. (“JGB”). Under the amendment, among other things, the maturity date of the debentures is extended by one year, from May 13, 2026 to May 13, 2027. In addition, beginning July 31, 2026, the quarterly principal amortization payments are reduced from $500,000 to $350,000. The next quarterly principal payment is due on July 31, 2026. The amendment is intended to provide AGI with additional...

Continue reading

Mount Logan Capital Inc. Schedules Release of First Quarter 2026 Results

NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) — Mount Logan Capital Inc. (Nasdaq: MLCI) (“Mount Logan” or the “Company”) announced today that it will release its financial results for the first quarter ended March 31, 2026, after market close on Thursday, May 14, 2026. The Company will host a conference call on Friday, May 15, 2026, at 1:00 p.m. Eastern Time to discuss its financial results. Shareholders, prospective investors, and analysts are welcome to listen to the conference call. To join the call, please use the dial-in information below. A recording of the conference call will be available following the event on Mount Logan’s Investor Relations website https://ir.mountlogan.com in the Financial Info section under “Financial Results”. To Participate in the Conference Call: Dial-in at least five minutes prior to start time: https://register-conf.media-server.com/register/BI44a527c38fef476287ac448d7f6b2dde Webcast...

Continue reading

Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance

Q1 2026 net revenue growth year-over year for Acute Care franchise (+32%), including ZYNRELEF® (+27%) and APONVIE® (+50%) Q1 2026 total net revenue of $34.7 million Reached settlement with Baxter Healthcare Corporation in CINVANTI® patent litigation Reaffirmed 2026 full-year guidance of $173–$183 million net revenue; $10–$20 million Adjusted EBITDACARY, N.C., May 11, 2026 (GLOBE NEWSWIRE) — Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or the “Company”), a commercial-stage biotechnology company, today announced financial results for the three months ended March 31, 2026, and highlighted recent corporate updates. “Despite typical first-quarter seasonality and unusual weather-related disruption early in the quarter, we saw a clear recovery in February and March,” said Craig Collard, Chief Executive Officer of Heron. “Our Acute...

Continue reading

Boost Run (“BRUN”) Begins Trading on Nasdaq with $940 Million of Contracted Customer Revenue

NORTHBROOK, Ill., May 11, 2026 (GLOBE NEWSWIRE) — Boost Run, Inc. (Nasdaq: BRUN), an NVIDIA Preferred Cloud Partner operating in adherence with NVIDIA Reference Architecture standards, today provided an operational and financial update reflecting continued commercial momentum, expanding deployment capacity and disciplined execution. “Contracted demand and deployment continue moving in lockstep,” said Andrew Karos, Founder and CEO of Boost Run. “With the majority of our contracted revenue already in production and the remainder tied to scheduled deployments through fiscal 2026, we have clear visibility into recurring revenue as capacity comes online.” Operational and Financial Highlights Contracted RevenueBoost Run enters its Nasdaq listing with $940M in long-term contracted revenue across its customer portfolio, with average contract...

Continue reading

Drilling Commences on the Rip Copper-Molybdenum Project

VANCOUVER, British Columbia, May 11, 2026 (GLOBE NEWSWIRE) — Copper Quest Exploration Inc. (CSE: CQX; OTCQB: IMIMF; FRA: 3MX) (“Copper Quest” or the “Company”) is pleased to announce that drilling has commenced on the Rip Copper-Molybdenum Project (the “Project” or “RIP”) for drilling a minimum of 2,000 meters. The RIP Project is in the Stikine region of British Columbia, situated approximately 33 km northeast of Imperial Metals Corporation’s past producing Huckleberry copper-molybdenum (“Cu-Mo”) mine and Surge Copper’s advanced stage Ox/Seal/Berg projects, and 30 km southeast of Vizsla Copper Corp’s Poplar copper-gold Project. Imperial Metals Corporation is exploring Huckleberry and its surrounding claims for additional Cu-Mo resources. Highlights of the Rip Copper-Molybdenum Project:First phase drill testing at Rip has confirmed...

Continue reading

Lavish Enterprises Acquires Exclusive, Perpetual Rights to FleetPath, an AI-Native Operating System for the Nearly $1 Trillion American Trucking Industry

Production-grade platform built, operational, and approaching beta deployment in a sector still running on fragmented, decades-old software. First in a series of structured disclosures issued under Lavish Enterprises, Inc. (OTC: VXIT). Full platform overview available at fleetpath.co. LAS VEGAS, May 11, 2026 (GLOBE NEWSWIRE) — via IBN — Lavish Enterprises, Inc. (OTC: VXIT) (“Lavish” or the “Company”) today announced it has executed a definitive agreement to acquire exclusive, perpetual, and irrevocable commercial rights to FleetPath, an AI-native operating system that connects every stage of the freight lifecycle for trucking carriers, brokers, shippers, and drivers inside a single intelligent platform. FleetPath is built, operational, and approaching beta-stage deployment. This is not a concept, a roadmap, or a forward-looking...

Continue reading

TRWD Files to Change SIC Code, Further Executing on Its Vision

NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) — Tradewinds Universal (OTCID: TRWD) today announced that it has filed to change its Standard Industrial Classification code to 6719 — Offices of Holding Companies — a designation that underscores the Company’s transformation into a multi-vertical holding company and reinforces its deliberate strategy of uplisting to a senior national exchange. The updated classification will be reflected in upcoming filings going forward. The change formalizes TRWD’s progression into a diversified holding company anchored in the experiential entertainment sector. Through its partnership with Alan Chang, founder of Peppermint Hippo and one of the most experienced operators in the gentlemen’s club industry, the Company is actively building an acquisition pipeline of revenue-generating clubs. TRWD’s structure...

Continue reading

Standard Lithium Reports First Quarter 2026 Results

Signed First Binding Customer Offtake Agreement with Trafigura Achieved Major Operational Milestones at Demonstration Plant Highlighted by 1 Million Barrels of Processed Smackover Brine and 15,000 DLE Cycles over 6 Years Remains On Track for a Final Investment Decision and Beginning Construction at the South West Arkansas Project (the “SWA Project”) in 2026VANCOUVER, British Columbia, May 11, 2026 (GLOBE NEWSWIRE) — Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE.A: SLI), a leading near-commercial lithium company, today announced its financial and operating results for the three-month period ended March 31, 2026. “We had an active first quarter and year to date as we continue to advance important milestones and deliverables for the Company,” said David Park, Chief Executive Officer and Director of...

Continue reading

Haoxi Health Technology Ltd Announces $6.5 Million Registered Direct Offering

BEIJING, May 11, 2026 (GLOBE NEWSWIRE) — Haoxi Health Technology Ltd (NASDAQ: HAO) (“Haoxi” or the “Company”) today announced that it has entered into a definitive agreement with certain investors for the purchase and sale of an aggregate of approximately $6.5 million of the Company’s securities, including 9,000,000 Class A ordinary shares, par value $0.0025 per share (the “Shares”) and 16,999,998 pre-funded warrants, at a purchase price of $0.25 per share in a registered direct offering. The purchase price for the pre-funded warrants is identical to the purchase price for Shares, less the exercise price of $0.0026 per share. Each pre-funded warrant is exercisable to purchase 10.355 Shares. The aggregate gross proceeds to the Company of this offering are expected to be approximately $6.5 million, before deducting placement agent...

Continue reading

Exagen Inc. Reports First Quarter 2026 Results

Delivers record total revenue and AVISE(R) CTD average selling price CARLSBAD, Calif., May 11, 2026 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31, 2026, and recent corporate updates.    Three Months Ended March 31,      2026     2025Unaudited. In thousands, except ASP data.    Revenue   $ 17,306     $ 15,498  Gross margin     59.0 %     58.9 %Operating expenses   $ 13,619     $ 12,488  Operating loss   $ (3,414 )   $ (3,365 )Net loss   $ (3,967 )   $ (3,752 )Adjusted EBITDA   $ (2,160 )   $ (2,508 )Trailing-twelve-month average selling price (ASP)   $ 444     $ 419  Cash and cash equivalents   $ 21,513     $ 11,194                   First Quarter 2026 Highlights:Achieved record...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.